GenHealth.ai
Markets
Use Cases
Products
Company
Docs
Get a Demo
Automated Prior Authorization
with Generative AI. See how we support health plans and providers with prior auth.
Generative AI Healthcare Analytics
Use natural language to ask any question of your data: past, present, and future.
Search all medical codes
T42.3X5S
Adverse effect of barbiturates, sequela
ICD10CM code
Similar Codes
ICD10CM codes
T42.3X5S
- Adverse effect of barbiturates, sequela
T42.4X5S
- Adverse effect of benzodiazepines, sequela
T42.3X5
- Adverse effect of barbiturates
T42.3X5D
- Adverse effect of barbiturates, subsequent encounter
T42.3X6S
- Underdosing of barbiturates, sequela
T42.3X5A
- Adverse effect of barbiturates, initial encounter
T42.3X1S
- Poisoning by barbiturates, accidental (unintentional), sequela
T42.6X5S
- Adverse effect of other antiepileptic and sedative-hypnotic drugs, sequela
T42.3X4S
- Poisoning by barbiturates, undetermined, sequela
T43.8X5S
- Adverse effect of other psychotropic drugs, sequela
HCPCS codes
G6043
- Barbiturates, not elsewhere specified
D9248
- NON-INTRAVENOUS CONSCIOUS SEDATION
G8947
- One or more neuropsychiatric symptoms
G6031
- Benzodiazepines
G6052
- Meprobamate
G9583
- Patients prescribed opiates for longer than six weeks
T1009
- Child sitting services for children of the individual receiving alcohol and/or substance abuse servi
G9561
- Patients prescribed opiates for longer than six weeks
H0010
- Alcohol and/or drug services; sub-acute detoxification (residential addiction program inpatient)
G9577
- Patients prescribed opiates for longer than six weeks
CPT4 codes
80345
- Barbiturates
80184
- Phenobarbital
80347
- Benzodiazepines; 13 or more
80368
- Sedative hypnotics (non-benzodiazepines)
80154
- Benzodiazepines
4328F
- Patient (or caregiver) queried about sleep disturbances (Prkns)
80346
- Benzodiazepines; 1-12
32120
- Thoracotomy; for postoperative complications
99140
- Anesthesia complicated by emergency conditions (specify) (List separately in addition to code for pr
4306F
- Patient counseled regarding psychosocial and pharmacologic treatment options for opioid addiction (S